aryliodide (2 eq.) and tripotassium phosphate (2 eq.) in
50% DME in water (0.1–0.2 M) was added dichloro-
bis(triphenylphosphine)palladium(II) (5 mol%). The resulting
reaction mixture was stirred at reflux for 18 hours. The crude
reaction mixture was extracted with EtOAc (3 ¥ 10 mL) and dried
over Na2SO4. Further purification by flash chromatography on
silica gel (20% EtOAc in PE) gave products 7–9.
(m), 1199 (w), 994 (w), 841 (m), 750 (w) cm-1; HRMS (ES): m/z
[MH]+ calcd. for C15H20ON2Si 272.1345, found 272.1334.
Using general method B: boronic ester 4 (50 mg, 0.16 mmol), 4-
iodophenol (72 mg, 0.33 mmol), tripotassium phosphate (70 mg,
0.33 mmol), dichlorobis(triphenylphosphine)palladium(II) (6 mg,
0.01 mmol) and 50% DME in water (2 mL), gave product 8 (22 mg,
50%) as a yellow solid.
Synthesis
of
3-(4-methoxy-phenyl)-2-trimethylsilanyl-5,6-
General method B: Microwave assisted Suzuki cross-coupling of
3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trimethylsilyl)-
5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole 4 with aryliodide. To 6
(1 eq.), aryliodide (2 eq.) and tripotassium phosphate (2 eq.)
in 50% DME in water (0.1–0.2 M) was added dichloro-
bis(triphenylphosphine)palladium(II) (5 mol%). The resulting
reaction mixture was heated at 130 ◦C for 1 hour in a sealed
microwave vessel in a microwave reactor. The crude reaction
mixture was extracted with EtOAc (3 ¥ 10 mL) and dried over
Na2SO4. Further purification by flash chromatography on silica
gel (20% EtOAc in PE) gave products 7–9.
dihydro-4H-pyrrolo[1,2-b]pyrazole 9. Using general method
A: Boronic ester 6 (50 mg, 0.16 mmol), 4-iodoanisole (75 mg,
0.33 mmol), tripotassium phosphate (70 mg, 0.33 mmol),
dichlorobis(triphenylphosphine)palladium(II) (6 mg, 0.01 mmol)
and 50% DME in water (2 mL), gave product 9 (35 mg, 74%)
as a yellow solid. M.p. 86–88 C; H NMR (250 MHz, CDCl3):
dH 7.25–7.22 (2H, m, Ar), 6.93–6.89 (2H, m, Ar), 4.22 (2H, t,
J = 7.0 Hz, CH2), 3.84 (3H, s, CH3), 2.88 (2H, t, J = 7.0 Hz,
CH2), 2.71–2.60 (2H, m, CH2), 0.21 (9H, s, CH3); 13C NMR
(100.6 MHz, CDCl3): dC 158.5, 156.1, 144.8, 130.4, 127.9, 122.7,
113.9, 55.7, 48.0, 27.3, 22.6, 0.2; FTIR (CH2Cl2): 2955 (w), 1556
(w), 1506 (m), 1246 (s), 1175 (w), 990 (w), 838 (s), 758 (w) cm-1;
HRMS (ES): m/z [MH]+ calcd. for C16H22ON2Si 286.1501, found
286.1504.
◦
1
General method C: Synthesis of withasomnine natural products 1–
3. A solution of pyrazole 7, 8 or 9 (1 eq.) in TBAF (1M in THF)
(10 eq.) was heated at reflux for 24 hours. The crude reaction
mixture was extracted with EtOAc (3 ¥ 10 mL) and dried over
Na2SO4. Further purification by flash chromatography on silica
gel (100% Et2O) gave products 1–3.
Using general method B: boronic ester 6 (50 mg, 0.16 mmol), 4-
iodoanisole (75 mg, 0.33 mmol), tripotassium phosphate (70 mg,
0.33 mmol), dichlorobis(triphenylphosphine)palladium(II) (6 mg,
0.01 mmol) and 50% DME in water (2 mL), gave product 9 (25 mg,
54%) as a yellow solid.
Synthesis
pyrrolo[1,2-b]pyrazole 7. Using general method A: Boronic
ester (100 mg, 0.33 mmol), iodobenzene (13 mg,
of
3-phenyl-2-trimethylsilanyl-5,6-dihydro-4H-
Synthesis of withasomnine 1. Using general method C: Pyra-
zole 7 (30 mg, 0.12 mmol) and TBAF (1 M in THF) (1.2 mL,
1.17 mmol), gave product 1 (15 mg, 70%) as a colourless solid. M.p.
114–116 ◦C. This sample of withasomnine 1 showed identical
analytical data (1H, 13C, HRMS) to that reported.2a,c 1H NMR
(250 MHz, CDCl3): dH 7.82 (1H, s, Ar), 7.47–7.16 (5H, m, Ar)
4.18 (2H, t, J = 7.0 Hz, CH2), 3.10 (2H, t, J = 7.0 Hz, CH2) 2.69
(2H, m, CH2); 13C NMR (100.6 MHz, CDCl3): dC 142.6, 140.9,
133.4, 128.8, 125.6, 125.0, 115.3, 47.5, 26.4, 23.8; HRMS (ES):
m/z [MH]+ calcd. for C12H12N2 184.1006, found 184.1000.
6
0.65 mmol), tripotassium phosphate (140 mg, 0.65 mmol),
dichlorobis(triphenylphosphine)palladium(II) (12 mg, 0.02 mmol)
and 50% DME in water (2 mL), gave product 7 (65 mg, 78%) as a
yellow solid. M.p. 118–120 ◦C; 1H NMR (250 MHz, CDCl3): dH
7.33–7.16 (5H, m, Ar), 4.16 (2H, t, J = 7.0 Hz, CH2), 2.84 (2H, t,
J = 7.0 Hz, CH2), 2.65–2.54 (2H, m, CH2), 0.15 (9H, s, CH3); 13
C
NMR (100.6 MHz, CDCl3): dC 156.1, 145.0, 135.6, 129.2, 128.5,
126.6, 123.1, 48.0, 27.3, 22.7, 0.2; FTIR (CH2Cl2): 2966 (w), 1602
(m), 1540 (w), 1498 (w), 1434 (w), 1247 (s), 987 (m), 842 (s), 756
(s) cm-1; HRMS (ES): m/z [MH]+ calcd. for C15H20N2Si 256.1396,
found 256.1384.
Synthesis of 4¢-hydroxywithasomnine 2. Using general method
C: Pyrazole 8 (28 mg, 0.10 mmol) and TBAF (1 M in THF)
(1.0 mL, 1.00 mmol), gave product 2 (11 mg, 55%) as a colourless
Using general method B: boronic ester 6 (50 mg, 0.16 mmol),
iodobenzene (3.6 mg, 0.33 mmol), tripotassium phosphate (70 mg,
0.33 mmol), dichlorobis(triphenylphosphine)palladium(II) (6 mg,
0.01 mmol) and 50% DME in water (2 mL), gave product 7 (32 mg,
76%) as a yellow solid.
◦
solid. M.p. 232–234 C. This sample of 4¢-hydroxywithasomnine
2 showed identical analytical data (1H, 13C, HRMS) to that
reported.2a,b
,
1H NMR (250 MHz, CDCl3:CD3OD (1:1)): dH 7.51
3
(1H, s, Ar), 7.10 (2H, d, J = 8.0 Hz, Ar), 6.66 (2H, d, J =
8.0 Hz, Ar), 3.96 (2H, t, J = 7.0 Hz, CH2), 3.17 (1H, s, OH),
2.89 (2H, t, J = 7.5 Hz, CH2) 2.52 (2H, m, CH2); 13C NMR
(125.8 MHz, CDCl3:CD3OD (1:1)): dC 154.9, 142.1, 139.7, 126.0,
124.2, 115.3, 115.3, 47.0, 26.0, 23.2. HRMS (ES): m/z [MH]+
calcd. for C12H12N2O 200.0956, found 200.0950.
Synthesis of 4-(2-trimethylsilanyl-5,6-dihydro-4H-pyrrolo[1,2-
b]pyrazol-3-yl)-phenol 8. Using general method A: Boronic ester
6 (50 mg, 0.16 mmol), 4-iodophenol (72 mg, 0.33 mmol),
tripotassium phosphate (70 mg, 0.33 mmol), dichloro-
bis(triphenylphosphine)palladium(II) (6 mg, 0.01 mmol) and 50%
DME in water (2 mL◦), gave product 8 (29 mg, 65%) as a yellow
Synthesis of 4¢ methoxywithasomnine 3. Using general method
C: pyrazole 9 (40 mg, 0.14 mmol) and TBAF (1 M in THF)
(1.4 mL, 1.40 mmol), gave product 3 (25 mg, 83%) as a colourless
solid. M.p. 123–125 ◦C. This sample of 4¢-methoxywithasomnine
3 showed identical analytical data (1H, 13C, HRMS) to that
reported.2b 1H NMR (250 MHz, CDCl3): dH 7.74 (1H, s, Ar),
7.37 (2H, d, J = 8.0 Hz, Ar), 6.91 (2H, d, J = 8.0 Hz, Ar),
4.16 (2H, t, J = 7.0 Hz, CH2), 3.82 (3H, s, CH3), 3.06 (2H, t,
1
solid. M.p. 198–202 C; H NMR (250 MHz, CDCl3:CD3OD
(1:1)): dH 6.83 (2H, d, J = 8.0 Hz, Ar), 6.53 (2H, d, J = 8.0 Hz,
Ar), 3.88 (2H, t, J = 7.0 Hz, CH2), 3.05 (1H, s, OH), 2.57 (2H, t,
J = 7.0 Hz, CH2), 2.41–2.37 (2H, m, CH2), 0.13 (9H, s, CH3); 13
C
NMR (100.6 MHz, CDCl3:CD3OD (1:1)): dC 155.5 (2 C), 144.8,
130.0, 125.9, 122.8, 114.8, 47.2, 26.7, 21.8, 0.8; FTIR (CH2Cl2):
3117 (s), 2923 (w), 1610 (w), 1541 (m), 1506 (w), 1428 (w), 1269
This journal is
The Royal Society of Chemistry 2009
Org. Biomol. Chem., 2009, 7, 4052–4056 | 4055
©